Cargando…

Impact of effective prevention and management of febrile neutropenia

Chemotherapy-induced febrile neutropenia is costly in both financial and human terms. The associated costs can be reduced substantially through the development and implementation of national policies and locally agreed protocols for the prevention and management of febrile neutropenia. Patients, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Krell, D, Jones, A L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752228/
https://www.ncbi.nlm.nih.gov/pubmed/19756004
http://dx.doi.org/10.1038/sj.bjc.6605273
_version_ 1782172284572663808
author Krell, D
Jones, A L
author_facet Krell, D
Jones, A L
author_sort Krell, D
collection PubMed
description Chemotherapy-induced febrile neutropenia is costly in both financial and human terms. The associated costs can be reduced substantially through the development and implementation of national policies and locally agreed protocols for the prevention and management of febrile neutropenia. Patients, the NHS, healthcare professionals and the broader community all stand to benefit from a commitment to effective management of this common and predictable side effect of some chemotherapy regimens for early-stage breast cancer.
format Text
id pubmed-2752228
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27522282010-09-01 Impact of effective prevention and management of febrile neutropenia Krell, D Jones, A L Br J Cancer Full Paper Chemotherapy-induced febrile neutropenia is costly in both financial and human terms. The associated costs can be reduced substantially through the development and implementation of national policies and locally agreed protocols for the prevention and management of febrile neutropenia. Patients, the NHS, healthcare professionals and the broader community all stand to benefit from a commitment to effective management of this common and predictable side effect of some chemotherapy regimens for early-stage breast cancer. Nature Publishing Group 2009-09 2009-09-15 /pmc/articles/PMC2752228/ /pubmed/19756004 http://dx.doi.org/10.1038/sj.bjc.6605273 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Full Paper
Krell, D
Jones, A L
Impact of effective prevention and management of febrile neutropenia
title Impact of effective prevention and management of febrile neutropenia
title_full Impact of effective prevention and management of febrile neutropenia
title_fullStr Impact of effective prevention and management of febrile neutropenia
title_full_unstemmed Impact of effective prevention and management of febrile neutropenia
title_short Impact of effective prevention and management of febrile neutropenia
title_sort impact of effective prevention and management of febrile neutropenia
topic Full Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752228/
https://www.ncbi.nlm.nih.gov/pubmed/19756004
http://dx.doi.org/10.1038/sj.bjc.6605273
work_keys_str_mv AT krelld impactofeffectivepreventionandmanagementoffebrileneutropenia
AT jonesal impactofeffectivepreventionandmanagementoffebrileneutropenia